C. D. Bock

LYMPHOID NEOPLASIA ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia

F. Speleman, J. Soulier, E. Clappier, 2014 .

Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo

S. Ackland, J. Sakoff, L. Lincz, 2011, The Pharmacogenomics Journal.

Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia

F. Speleman, J. Soulier, B. Poppe, 2015, Leukemia.

JAK3 Mutants Transform Hematopoietic Cells through JAK1 Activation Causing T-Cell Acute Lymphoblastic Leukemia in a Bone Marrow Transplant Mouse Model

K. Jacobs, J. Cools, T. Tousseyn, 2014 .

Generation of the Fip1l1–Pdgfra fusion gene using CRISPR/Cas genome editing

S. Demeyer, J. Cools, C. D. de Bock, 2016, Leukemia.